MgShell

GelMEDIX

GelMEDIX develops injectable hydrogel scaffolds and regenerative cell therapies to treat degenerative ocular diseases such as geographic atrophy for patients with vision loss.

EYE-GO

This company develops a microdosing delivery system for ophthalmic medications to assist patients with precise and easier administration of eye care treatments.

Oxular

Oxular develops drug delivery devices and sustained-release therapeutics for treating retinal diseases in patients with vision disorders.

Pykus

This company develops a biodegradable hydrogel retinal sealant to assist recovery for patients undergoing vitrectomy surgery.

Neuro Modulation Artificial Retina

This company develops a high-acuity spherical bionic retinal implant to restore vision for patients with retinitis pigmentosa or age-related macular degeneration.

Biophta

This company develops self-administered ocular inserts providing seven-day continuous drug release for patients with glaucoma and macular oedema.

Azalea Vision

This company develops smart contact lenses with integrated microelectronics to treat patients suffering from vision disorders and light sensitivity.

Maculaser

The company develops temperature-controlled laser therapy devices for ophthalmologists to treat retinal disorders such as age-related macular degeneration and diabetic macular oedema.